Loading clinical trials...
Loading clinical trials...
Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic Veno-occlusive Disease in Children With Nephroblastoma or Acute Lymphoblastic Leukemia
Conditions
Interventions
Blood test for genetic analysis
Locations
16
France
Univesity Hostipal of Amiens
Amiens, France
University Hospital of Bordeaux
Bordeaux, France
University of Brest
Brest, France
University Hospital of Dijon
Dijon, France
Centre Oscar Lambret
Lille, France
University Hospital of Limoges
Limoges, France
Start Date
January 1, 2020
Primary Completion Date
January 1, 2022
Completion Date
January 1, 2022
Last Updated
November 19, 2019
NCT05376111
NCT04065399
NCT07295951
NCT05453500
NCT05442515
NCT03970096
Lead Sponsor
University Hospital, Angers
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions